BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 18481389)

  • 1. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.
    Feuchtinger T; Richard C; Joachim S; Scheible MH; Schumm M; Hamprecht K; Martin D; Jahn G; Handgretinger R; Lang P
    J Immunother; 2008; 31(2):199-206. PubMed ID: 18481389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.
    Feuchtinger T; Matthes-Martin S; Richard C; Lion T; Fuhrer M; Hamprecht K; Handgretinger R; Peters C; Schuster FR; Beck R; Schumm M; Lotfi R; Jahn G; Lang P
    Br J Haematol; 2006 Jul; 134(1):64-76. PubMed ID: 16803570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.
    Feuchtinger T; Lang P; Hamprecht K; Schumm M; Greil J; Jahn G; Niethammer D; Einsele H
    Exp Hematol; 2004 Mar; 32(3):282-9. PubMed ID: 15003314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS; Mackinnon S
    Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy.
    Lugthart G; Albon SJ; Ricciardelli I; Kester MG; Meij P; Lankester AC; Amrolia PJ
    J Immunother; 2012 Jan; 35(1):42-53. PubMed ID: 22130159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid generation of full clinical-grade human antiadenovirus cytotoxic T cells for adoptive immunotherapy.
    Aïssi-Rothé L; Decot V; Venard V; Jeulin H; Salmon A; Clement L; Kennel A; Mathieu C; Dalle JH; Rauser G; Cambouris C; de Carvalho M; Stoltz JF; Bordigoni P; Bensoussan D
    J Immunother; 2010 May; 33(4):414-24. PubMed ID: 20386465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors.
    Comoli P; Schilham MW; Basso S; van Vreeswijk T; Bernardo ME; Maccario R; van Tol MJ; Locatelli F; Veltrop-Duits LA
    J Immunother; 2008; 31(6):529-36. PubMed ID: 18528302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(HELPER) cells following stem cell transplantation.
    Serangeli C; Bicanic O; Scheible MH; Wernet D; Lang P; Rammensee HG; Stevanovic S; Handgretinger R; Feuchtinger T
    Virology; 2010 Feb; 397(2):277-84. PubMed ID: 19962170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capture and generation of adenovirus specific T cells for adoptive immunotherapy.
    Chatziandreou I; Gilmour KC; McNicol AM; Costabile M; Sinclair J; Cubitt D; Campbell JD; Kinnon C; Qasim W; Gaspar HB
    Br J Haematol; 2007 Jan; 136(1):117-26. PubMed ID: 17092305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
    Hammer MH; Brestrich G; Mittenzweig A; Roemhild A; Zwinger S; Subklewe M; Beier C; Kurtz A; Babel N; Volk HD; Reinke P
    J Immunother; 2007; 30(8):817-24. PubMed ID: 18049333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markers.
    Leibold J; Feucht J; Halder A; Stevanovic S; Kayser S; Handgretinger R; Feuchtinger T
    J Immunother; 2012; 35(9):661-9. PubMed ID: 23090075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection.
    Zandvliet ML; Falkenburg JH; van Liempt E; Veltrop-Duits LA; Lankester AC; Kalpoe JS; Kester MG; van der Steen DM; van Tol MJ; Willemze R; Guchelaar HJ; Schilham MW; Meij P
    Haematologica; 2010 Nov; 95(11):1943-51. PubMed ID: 20562315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update.
    Feuchtinger T; Richard C; Pfeiffer M; Neuhäuser F; Lücke J; Handgretinger R; Greil J; Bader P; Klingebiel T; Schlegel PG; Jahn G; Niethammer D; Lang P
    Klin Padiatr; 2005; 217(6):339-44. PubMed ID: 16307420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.
    Zandvliet ML; van Liempt E; Jedema I; Kruithof S; Kester MG; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2011 Apr; 34(3):307-19. PubMed ID: 21389867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells.
    Mackinnon S; Thomson K; Verfuerth S; Peggs K; Lowdell M
    Blood Cells Mol Dis; 2008; 40(1):63-7. PubMed ID: 17869548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
    J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of cytotoxic T-cell lines using overlapping pentadecapeptides derived from conserved regions of the adenovirus hexon protein.
    Zhu F; Xu H; Tsao A; Margolis DA; Keever-Taylor CA
    J Gen Virol; 2010 Jun; 91(Pt 6):1577-89. PubMed ID: 20130135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of Hexon- and Penton-selected adenovirus-specific T cells for refractory adenovirus infection after haploidentical stem cell transplantation.
    Schultze-Florey RE; Tischer-Zimmermann S; Heuft HG; Priesner C; Lamottke B; Heim A; Sauer M; Sykora KW; Blasczyk R; Eiz-Vesper B; Maecker-Kolhoff B
    Transpl Infect Dis; 2020 Feb; 22(1):e13201. PubMed ID: 31643129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.